CYP19A1 and breast cancer: Therefore, the application of aromatase inhibitors in women results in a significant reduction in estrogen synthesis[39,41], as seen, for example, in women with breast cancer, where the conversion of androgens to estrogens takes place directly in the tumor cells[39,45,46].